Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrique Esteve-Valverde

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Archives of Gynecology and Obstetrics|May 4, 2021
Immunological and physiopathological approach of COVID-19 in pregnancyRaquel Ferrer-Oliveras, Manel Mendoza, Sira Capote, et al.
Autoimmunity Reviews|October 31, 2021
Proteomics and enriched biological processes in Antiphospholipid syndrome: A systematic reviewAriadna Anunciación-Llunell, Francesc Miró-Mur, Enrique Esteve-Valverde, et al.
Reumatologia Clinica|December 6, 2023
The "autoimmune/inflammatory syndrome induced by adjuvants" (ASIA) after COVID-19 infection: A case reportPatricia Aguilera-Fernandez, María Del Carmen Navarro-Saez, Carlos Feijoo-Massó, et al.
Psychoneuroendocrinology|October 23, 2024
Lymphocyte-derived and lipoprotein-derived inflammatory ratios as biomarkers in bipolar disorder type I: Characteristics, predictive values, and influence of current psychopharmacological treatmentsLourdes Villegas García, Esther Patró, Juan David Barbero, et al.
International Journal of Molecular Sciences|November 11, 2022
Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid SyndromeAriadna Anunciación-Llunell, Cándido Muñoz, Dirk Roggenbuck, et al.
Research and Practice in Thrombosis and Haemostasis|August 5, 2025
The absence of standardization in antiphospholipid antibody testing may favor the use of 99th percentile cutoffs in antiphospholipid syndrome classificationAriadna Anunciación-Llunell, Joana Marques-Soares, Monika Ockova, et al.
Autoimmunity Reviews|May 8, 2020
Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive reviewJaume Alijotas-Reig, Enrique Esteve-Valverde, Cristina Belizna, et al.
Clinical Immunology (Orlando, Fla.)|March 30, 2019
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) demonstrates distinct autoimmune and autoinflammatory disease associations according to the adjuvant subtype: Insights from an analysis of 500 casesAbdulla Watad, Nicola Luigi Bragazzi, Dennis McGonagle, et al.
Autoimmunity Reviews|October 31, 2025
Are the 2023 ACR/EULAR classification criteria a step forward in the management of antiphospholipid syndrome? A literature-based and clinical practice appraisalJaume Alijotas-Reig, Joana Marques-Soares, Enrique Esteve-Valverde, et al.
Autoimmunity Reviews|May 22, 2026
Hydroxychloroquine and teratogenic risk in pregnancy in systemic autoimmune diseases: A systematic narrative reviewEnrique Esteve-Valverde, Francesc Miro-Mur, Ariadna Anunciacion-LLunell, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Archives of Gynecology and Obstetrics|May 4, 2021
Immunological and physiopathological approach of COVID-19 in pregnancyRaquel Ferrer-Oliveras, Manel Mendoza, Sira Capote, et al.
Autoimmunity Reviews|October 31, 2021
Proteomics and enriched biological processes in Antiphospholipid syndrome: A systematic reviewAriadna Anunciación-Llunell, Francesc Miró-Mur, Enrique Esteve-Valverde, et al.
Reumatologia Clinica|December 6, 2023
The "autoimmune/inflammatory syndrome induced by adjuvants" (ASIA) after COVID-19 infection: A case reportPatricia Aguilera-Fernandez, María Del Carmen Navarro-Saez, Carlos Feijoo-Massó, et al.
Psychoneuroendocrinology|October 23, 2024
Lymphocyte-derived and lipoprotein-derived inflammatory ratios as biomarkers in bipolar disorder type I: Characteristics, predictive values, and influence of current psychopharmacological treatmentsLourdes Villegas García, Esther Patró, Juan David Barbero, et al.
International Journal of Molecular Sciences|November 11, 2022
Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid SyndromeAriadna Anunciación-Llunell, Cándido Muñoz, Dirk Roggenbuck, et al.
Research and Practice in Thrombosis and Haemostasis|August 5, 2025
The absence of standardization in antiphospholipid antibody testing may favor the use of 99th percentile cutoffs in antiphospholipid syndrome classificationAriadna Anunciación-Llunell, Joana Marques-Soares, Monika Ockova, et al.
Autoimmunity Reviews|May 8, 2020
Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive reviewJaume Alijotas-Reig, Enrique Esteve-Valverde, Cristina Belizna, et al.
Clinical Immunology (Orlando, Fla.)|March 30, 2019
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) demonstrates distinct autoimmune and autoinflammatory disease associations according to the adjuvant subtype: Insights from an analysis of 500 casesAbdulla Watad, Nicola Luigi Bragazzi, Dennis McGonagle, et al.
Autoimmunity Reviews|October 31, 2025
Are the 2023 ACR/EULAR classification criteria a step forward in the management of antiphospholipid syndrome? A literature-based and clinical practice appraisalJaume Alijotas-Reig, Joana Marques-Soares, Enrique Esteve-Valverde, et al.
Autoimmunity Reviews|May 22, 2026
Hydroxychloroquine and teratogenic risk in pregnancy in systemic autoimmune diseases: A systematic narrative reviewEnrique Esteve-Valverde, Francesc Miro-Mur, Ariadna Anunciacion-LLunell, et al.
Pageof 4